Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients
NCT ID: NCT07122856
Last Updated: 2025-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
100 participants
OBSERVATIONAL
2025-09-15
2026-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predictive Value of Cognitive Tests Performed for the Diagnosis of Alzheimer's Disease and Related Disorders
NCT01316562
Predicting the Conversion From Mild Cognitive Impairment to Dementia
NCT01823666
Factors Associated With Mortality, Morbidity and Prognosis in Dementia Patients
NCT05052450
Patients With Alzheimer's Disease or Related Youth Disease
NCT03508024
Psychopathological Risk Factors Associated With Conversion From Mild Cognitive Impairment to Dementia
NCT01436552
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least two MMSE evaluations spaced 12 months apart
* Follow-up at the Memory Clinic of CH Gonesse
Exclusion Criteria
* Patient has moved out of the study area (outside the CH Gonesse territory)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier de Gonesse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Hospitalier de Gonesse
Gonesse, France, France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0114_NEUROLOGIE_TARGET MMSE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.